E-mail: kyra@vfn.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS.
- A Lack of Correlation between EVI1 Expression, MDS Subtype and Karyotype Abnormalities Suggests Multiple Pathways Involved in EVI1 Impact on Hematopoietic Cells in MDS Patients.
- Amplifikácia MLL génu u pacienta s akútnou myeloidnou leukémiou (AML)
- ANALYSIS OF 1458 ACUTE MYELOID LEUKEMIA FROM THE ALERT PROJECT (ACUTE LEUKEMIA CLINICAL REGISTER) IN THE CZECH REPUBLIC IN 1996-2006
- ANALYSIS OF RISK FACTORS OF 248 PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA AT DIAGNOSIS
- ATYPICAL DELETED SEGMENTS IN THREE PATIENTS WITH MYELOID MALIGNANCIES AND DELETION 5Q
- Biopsie sentinelové uzliny u karcinomu prsu v praxi a význam mikrometastáz
- Can Gene Methylation, Telomere Length and Activity of Telomerase Help with Individual Risk and Treatment Strategy of MDS Patients?
- Clinical Relevance of Complex Chromosomal Aberrations in Bone Marrow Cells of 107 Children with ETV6/RUNX1 Positive Acute Lymphoblastic Leukemia (ALL).
- CLONAL EVOLUTION STUDIED BY I-FISH IN B-CLL
- Clonal Heterogeneity in Patients with Myelodysplastic Syndromes (MDS) and Complex Karyotypes
- COMBINED IMMUNOSUPPRESSIVE TREATMENT IN PATIENTS WITH EARLY MYELODYSPLASIA
- COMPLEX CHROMOSOMAL ABERRATIONS IN BONE MARROW CELLS OF 86 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
- COMPLEX CHROMOSOMAL REARRANGEMENTS IN ADULT PATIENTS WITH AML ARE INDEPENDENT PROGNOSTIC FACTOR
- Composition of Cellular Subsets by Flow Cytometry Identifies Differences Between MDS Subtypes and Aplastic Anemia but No Differences Are Identified Between Cases with and without Monosomy 7
- CORRELATIONS AMONG CFU-GM GROWTH PATTERNS AND ACUTE LEUKEMIA WHO-2008 ENTITIES
- DASATINIB EVEN AT LOWER DOSES IS AN EFFECTIVE FOR CHRONIC MYELOID LEUKAEMIA TREATMENT IN PATIENTS RESISTANT OR INTOLERANT TO IMATINIB
- DETECTION OF STRUCTURAL ABERRATIONS OF CHROMOSOME 7 IN MYELOID MALIGNANCIES USING COMBINATION OF MOLECULAR CYTOGENETIC TECHNIQUES
- DIFFERENTIAL DNA METHYLATION IN AML PATIENTS WITH WILD-TYPE AND MUTATED DNMT3A AND PROGNOSTIC IMPACT OF DNA METHYLATION
- DNMT3A MUTATIONS IN INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA
- Druhá celostátní léčebná studie AML-BFM 98 zvýšila úspěšnost v dosažení remise i celkové přežití dětí s akutní myeloidní leukémií v České republice
- DYNAMICS OF TELOMERE LENGTH, THE STATUS OF CDKN2B GENE METHYLATION AND TELOMERASE ACTIVITY AS A POTENTIAL UNSPECIFIC PROGNOSTIC MARKERS IN MDS
- EFFECT OF LENALIDOMIDE TREATMENT ON THE EXPRESSION OF FLI1, EKLF, TP53, HDM2, PU. 1 AND IL-6 GENES IN 5Q- SYNDROME
- Fli-1 and EKLF Gene Expression in Patients with MDS 5q- Syndrome
- FREQUENCY AND CLINICAL IMPLICATIONS OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN ETV6/RUNX1 POSITIVE CHILDHOOD ALL
- Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q)
- GAIN/AMPLIFICATION OF 1Q21 IS THE MOST POWERFUL GENETIC PROGNOSTIC FACTOR FOR PATIENTS TREATED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
- High Cereblon Expression In Lower Risk Myelodysplastic Syndromes With 5q Deletion Is Associated With The Efficacy Of Lenalidomide
- HIGH LEVELS OF CEREBLON MESSENGER RNA ARE THE CHARACTERISTIC FEATURE OF LOWER RISK MYELODYSPLASTIC SYNDROMES WITH 5Q DELETION AND ARE CONNECTED WITH THE EFFICACY OF LENALIDOMIDE
- CHROMOSOME 3 ABERRATIONS IN MYELOID MALIGNANCIES REVEALED BY MOLECULAR CYTOGENETIC TECHNIQUES AND THEIR PROGNOSTIC SIGNIFICANCE
- CHROMOTHRIPSIS IN BONE MARROW CELLS OF ADULT PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) WITH COMPLEX KARYOTYPES
- I-FISH ANALYSIS OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
- IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS
- IMATINIB IN THE TREATMENT OF ELDERLY PATIENTS WITH PH CML IN THE LATE CHRONIC PHASE
- IMMUNO CHEMOTHERAPY (ANTI CD20 AND FLUDARABIN/CYCLOPHOSPHAMIDE) AND HIGH DOSE CHEMOTHERAPY WITH ASCT INCREASES MOLECULAR REMISSION RATE BUT CANNOT PREVENT RELAPSES
- Incidence a prognostický význam chromozomových změn u myelodysplastického syndromu
- Komplexní změny karyotypu u pacientů s mnohočetným myelomem (MM)
- Model klinického registru umožňujícího hodnocení léčebné péče: projekt ALERT (Akutní LEukémie – klinický RegisTr)
- Modification of WPSS for the Time of Diagnosis Retains Its Prognostic Impact and Confirms Transfusion Dependency as An Important Parameter Affecting Survival in Early MDS Patients with Isolated Erythroid Dysplasia
- Molecular Cytogenetic Studies of Complex Karyotypes in Myelodysplastic Syndromes (MDS): Conventional Cytogenetics, FISH and Multiplex FISH (mFISH/mBAND)
- MOLECULAR CYTOGENETIC STUDY OF CHILDHOOD T-ALL
- MOLECULAR CYTOGENETIC STUDY OF IMMUNOFLUORESCENTLY LABELED PLASMA CELLS AND PROGNOSTIC SIGNIFICANCE OF CLONAL CHROMOSOMAL ABERRATIONS IN 208 PATIENS WITH MULTIPLE MYELOMA
- Molecular Cytogenetic Study of Immunofluorescently Labeled Plasma Cells and Prognostic Significance of Clonal Chromosomal Aberrations in Multiple Myeloma.
- Molekulárně cytogenetická analýza buněk difúzních gliomů
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- Molekulárně cytogenetická analýza buněk mozkových tumorů
- MUTATIONS OF ASXL1 GENE IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETIC PROFILE
- Neinvazivní diagnostika karcinomu močového měchýře metodou I-FISH
- PROGNOSTIC SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN CHILDREN WITH ETV6-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF COMPLEX CHROMOSOMAL REARRANGEMENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
- PROGNOSTIC SIGNIFICANCE OF TELOMERE LENGTH, MOLECULAR CYTOGENETIC FINDINGS AND IMMUNOPHENOTYPIC FEATURES IN PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA
- Putative Monosomy 5 In Myelodysplastic Syndromes (MDS) Is Probably Resulting From Chromothripsis
- RESULTS OF CLONALITY ASSAY AND MEASUREMENT OF APOPTOTIC RATE AND TELOMERE LENGTH SUPPORT USEFULNESS OF SEPARATION OF REFRACTORY CYTOPENIA FROM REFRACTORY ANEMIA AS A DISTINCT SUBTYPE OF EARLY MDS
- Retrospektivní analýza imunofenotypu subpopulací v kostní dřeni u dětí s myelodysplastickým syndromem a aplastickou anémií
- SIGNIFICANCE OF ADDITIONAL STRUCTURAL ABERRATIONS IN BONE MARROW CELLS OF 115 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND HIGH HYPERDIPLOIDY
- Sledování klonálního vývoje u B-CLL metodou I-FISH
- Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency
- Standard Dose Chemotherapy 3+7 Induces Complete Remission in Patients Over 80 Years Old with Single-Lineage Acute Myeloid Leukemias and Normal Karyotype
- TELOMERE LENGTH EVALUATION IN PATIENTS WITH UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA - CORRELATION WITH OTHER MOLECULAR, CYTOGENETIC AND IMMUNOPHENOTYPIC FEATURES
- THE ROLE OF TP53 MUTATIONS IN LOW-RISK MDS PATIENTS
- The Significance of Megakaryocytic Transcription Factor Fli1 and Erythroid Transcription Factor EKLF in the Ribosomopathies: 5q Minus Syndrome and Diamond-Blackfan Anemia. the Role of Fli1 in p53 Regulation and in 5q Minus Syndrome Megakaryopoiesis
- THE UNUSUAL MLL REARRANGEMENT IN ACUTE MYELOID LEUKEMIA
- TRUE MONOSOMY OF CHROMOSOME 5 IS PRESUMABLY NOT AN ISOLATED CYTOGENETIC ENTITY IN MDS
- VARIATION OF TELOMERE-TELOMERASE COMPLEX COMPONENTS IN MYELODYSPLASTIC SYNDROMES: TELOMERE LENGTH AND EXPRESSION OF THE HTERT GENE SEEM TO BE THE MOST VALUABLE FOR DISEASE PROGNOSIS
- Význam metody I-FISH pro neinvazivní diagnostiku karcinomu močového měchýře.
- Význam mikrometastáz v sentinelové uzlině u karcinomu prsu
- Význam molekulárně cytogenetické analýzy nádorových buněk pro diagnostiku a léčbu oligodendrogliomů
- Význam radionavigované chirurgie pokročilých stadií karcinomu prsu po neoadjuvantní chemoterapii
Články v Klinické onkologii
- Model populačního klinického registru umožň ujícího hodnocení léčebné péče: projekt ALERT (akutní leukemie-klinický registr)
- Molekulárně cytogenetická analýza chromozomových aberací v buňkách nízkostupňových gliomů a její přínos pro klasifikaci nádoru
- Prohlášení Společnosti lékařské genetiky ČLS JEP k problematice prediktivního genetického testování
- Příklady využití:Výsledky molekulárně cytogenetické analýzy imunofluorescenčně značených plasmatických buněk u pacientů s MM zařazených ve studii CMG 2002
